The Systemic Effects of Blood Flow Restriction Training: A Systematic Review.
Bradley C Miller, Alexander W Tirko, Justin M Shipe and 2 others
PMID 34386277WHAT IT FOUND
Blood flow restriction training improves strength and aerobic capacity with low loads, but dosing varies widely.
It appears safe for healthy adults and some cardiac patients, though it increases perceived exertion and discomfort initially. Evidence for older adults and long-term systemic effects remains limited.
Key findings
01BFR combined with low-load exercise can improve functional capacity in patients with end-stage renal disease and heart failure without reported adverse effects.
02Perceived exertion and discomfort are higher initially with BFR compared to traditional high-load training, though tolerance may build over time.
03Dosing parameters such as cuff pressure and width varied significantly across studies, limiting the ability to standardize recommendations.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Dosing parameters (cuff width, pressure, duration) were not standardized across the included studies, making it difficult to determine the optimal protocol. Most studies involved healthy young adults (ages 18-39), so findings may not generalize to older adults or other clinical populations. There is a potential conflict of interest because some included studies were authored by Dr. Yoshiaki Sato, the inventor of KAATSU BFR products. Long-term systemic effects and safety in diverse patient groups remain unclear.
Declared interests
The authors declared no personal conflicts of interest. However, they noted that several included studies were co-authored by Dr. Yoshiaki Sato, who holds patents on BFR products, which may bias the evidence base.
The easy way to misread this
Do not assume BFR is universally safe or effective for all patients. The review highlights that high pressures can negatively impact vascular health, and initial discomfort may deter adherence. Additionally, the evidence is heavily influenced by studies from the inventor of one BFR method, and dosing is not standardized.